Please use this identifier to cite or link to this item:
Title: Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival
Authors: Yang, E.-B.
Tang, W.-Y.
Zhang, K.
Cheng, L.-Y. 
Mack, P.O.P.
Keywords: Adriamycin
Hepatocellular carcinoma
Liver cancer
Mitomycin C
Issue Date: 15-Jul-1997
Citation: Yang, E.-B., Tang, W.-Y., Zhang, K., Cheng, L.-Y., Mack, P.O.P. (1997-07-15). Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Letters 117 (1) : 93-98. ScholarBank@NUS Repository.
Abstract: In this study, norcantharidin was compared with adriamycin and mitomycin C for its inhibitory action in the growth of cultured human hepatocellular carcinoma HepG2 cells. The IC 50 of adriamycin and mitomycin C on HepG2 cells was 7.3 μM and 27 μM, respectively, whereas the IC 50 of norcantharidin for inhibiting the growth of HepG2 cells was as high as 1900 μM. After HepG2 tumor-bearing nude mice were treated with 12 daily intraperitoneal injections of norcantharidin (2 mg/kg), the increase in tumor size was significantly slower than that of untreated controls. The mean survival time of untreated tumor-bearing nude mice was 129 days, whereas in the tumor-bearing nude mice treated with norcantharidin, the mean survival time was significantly prolonged to 194 days (P < 0.0001). It is concluded that norcantharidin may have a potential role in the treatment of human hepatocellular carcinoma.
Source Title: Cancer Letters
ISSN: 03043835
DOI: 10.1016/S0304-3835(97)00206-1
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jan 21, 2019


checked on Jan 21, 2019

Page view(s)

checked on Jan 18, 2019

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.